Rajnish Wellness
0.41
+0.02(+5.13%)
Market Cap₹41.63 Cr
PE Ratio-7.80
IndustryHealthcare
Company Performance:
1D+5.13%
1M-2.38%
6M-12.77%
1Y-55.43%
5Y-44.59%
View Company Insightsright
More news about Rajnish Wellness
29Nov 25
Rajnish Wellness Limited Revises Half-Year Financial Results, Reports Profit Amid Rights Issue
Rajnish Wellness, listed on BSE, resubmitted unaudited financial results for the half-year ended September 30, 2025. The company reported a profit of Rs 27.98 lacs for the period. Revenue for the quarter ended September 30, 2025, was Rs 12.30 crore, showing a 161.70% increase from the previous quarter but a 29.31% decrease year-over-year. A rights issue in August 2025 raised Rs 246.87 lacs. The company's balance sheet as of March 31, 2025, showed total assets of Rs 91.30 crore (-14.11% YoY) and total equity of Rs 84.20 crore (+0.24% YoY). Current liabilities decreased by 73.05%, indicating improved short-term financial stability.
 no imag found
14Nov 25
Rajnish Wellness Reports Reduced Quarterly Loss, Completes Rights Issue
Rajnish Wellness Limited reported a net loss of Rs 2.90 lakhs for Q2 2025, an 89% improvement from the previous quarter's Rs 27.17 lakhs loss. The company successfully raised Rs 24.69 crore through a rights issue, allocating funds for acquisition, working capital, and corporate purposes. Total assets stood at Rs 12,130.88 lakhs, with total equity at Rs 10,912.92 lakhs. Despite operational cash outflow, the rights issue improved the company's liquidity position.
 no imag found
11Aug 25
Rajnish Wellness Limited Schedules Board Meeting for August 14, 2025 to Approve Quarterly Results and Registered Office Change
Rajnish Wellness Limited's Board of Directors will meet on August 14, 2025, to approve Q1 FY2025-26 unaudited standalone financial results. The board will also consider relocating the registered office from Mumbai to Vasai-East. The meeting will take place at the current registered office in Mumbai.
 no imag found
Rajnish Wellness
0.41
+0.02
(+5.13%)
1 Year Returns:-55.43%
Industry Peers
Sun Pharmaceutical
1,910.00
(+0.40%)
Divis Laboratories
8,496.00
(-1.17%)
Torrent Pharmaceuticals
4,886.50
(-0.20%)
Cipla
1,437.90
(+0.40%)
Zydus Life Science
1,103.80
(-1.45%)
Lupin
2,188.00
(-0.63%)
Dr Reddys Laboratories
1,190.00
(+1.30%)
Mankind Pharma
2,374.50
(-0.40%)
Laurus Labs
1,801.00
(-0.06%)
Aurobindo Pharma
1,608.00
(-0.82%)